[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626633":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":22,"collaborators":7,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":7,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":34,"maxAge":35,"enrollmentInfo":36,"targetDuration":7,"studyType":39,"phases":7,"briefSummary":40,"conditions":41,"keywords":44,"overallStatus":49,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":7},{"fullName":5,"class":6},"University of Novi Sad","OTHER",null,[9,13,16,19],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Bupivacaine %0.5 (hyperbaric)","Only Bupivacaine %0.5 (hyperbaric) for spinal anesthesia",{"type":10,"name":14,"description":15,"armGroupLabels":7,"otherNames":7},"Bupivacaine %0.5 (hyperbaric) and morphine","Combination of bupivacaine and morphine for spinal anesthesia",{"type":10,"name":17,"description":18,"armGroupLabels":7,"otherNames":7},"Bupivacaine %0.5 (hyperbaric), morphine and fentanyl 15","Bupivacaine %0.5 (hyperbaric) , morphine and fentanyl 15 mcg for spinal anesthesia",{"type":10,"name":20,"description":21,"armGroupLabels":7,"otherNames":7},"Bupivacaine, morphine and fentanyl 20","Bupivacaine, morphine and fentanyl 20 mcg for spinal anesthesia",{"type":23,"investigatorFullName":24,"investigatorTitle":25,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Pujic Borislava","MD, PhD","100626633","maternal-satisfaction-after-spinal-anesthesia-for-cesarean-delivery-100626633",false,"NCT07438171","Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery","Maternal Satisfaction Following Different Spinal Anesthesia Regimens for Elective Cesarean Delivery: a Prospective Observational Study","Inclusion Criteria: Parturients for elective cesarean delivery, ASA, status II and III, age between 18 and 45 years, singleton pregnancy, able to provide inform consent. -\n\nExclusion Criteria: Refuse to participate in the study, spinal anesthesia refused, known drug allergies to drugs included in the study, multiple pregnancy, preterm gestation, skin lesion at the beck, severe maternal comorbidities, chronic opioid use and chronic pain. -","FEMALE","18 Years","45 Years",{"count":37,"type":38},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the impact of four different spinal anesthesia regimens on maternal satisfaction following cesarean delivery.\n\nThe main questions this study aims to answer are:\n\n* Primary outcome: Patient satisfaction with the provided analgesia during the first 24 hours postoperatively.\n* Secondary outcome: The need for rescue analgesics. Participants will complete a specially designed questionnaire 24 hours after cesarean delivery.",[42,43],"Parturients","Elective Cesarean Delivery",[45,46,47,48],"Maternal satisfaction","Spinal anesthesia","cesarean delivery","postcesarean analgesia","NOT_YET_RECRUITING","2026-02-22",{"date":52,"type":53},"2026-02-27","ACTUAL",{"date":55,"type":38},"2026-03-02",{"date":57,"type":38},"2026-09-01",{"name":5,"class":6}]